| Dr Vanessa Lynn Dickey, MD | |
|
3285 Skypark Dr, Torrance, CA 90505-5004 | |
| (310) 750-3300 | |
| (310) 750-3381 |
| Full Name | Dr Vanessa Lynn Dickey |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 27 Years |
| Location | 3285 Skypark Dr, Torrance, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497742472 | NPI | - | NPPES |
| 00A68563 | Other | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A68563 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Torrance Memorial Medical Center | Torrance, CA | Hospital |
| Providence Little Company Of Mary Med Ctr Torrance | Torrance, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Torrance Health Association Inc | 1355302134 | 249 |
News Archive
Hepatocellular carcinoma is an aggressive tumor with poor long-term prognosis. The reported 5-year recurrence rate ranges from 75% to 100%. Therefore, extrahepatic metastasis of HCC is uncommon due to the highly malignant nature of the primary tumor. However, with advances in different treatment modalities for HCC, the incidence of extrahepatic metastasis appears to be increasing.
"Have you ever been sexually active for a year or more without using contraception and becoming pregnant?" A study by George Mason University's Dean of the College of Health and Human Services, Dr. Germaine M. Buck Louis, and colleagues from the University at Albany and Eunice Kennedy Shriver National Institute of Child Health and Human Development suggests that asking this question could help clinicians better understand women and infants' health.
Researchers from the University of Texas have found an immunosuppressing target for the treatment of glioblastoma. In mice studies the team has identified CD73 macrophages which could be used to treat the cancers. The team also performed studies on human tumours to arrive at their conclusions. The study was published in the latest issue of the journal Nature Medicine this week.
Cancer painfully ends more than 500,000 lives in the United States each year, according to the Centers for Disease Control and Prevention. The scientific crusade against cancer recently achieved a victory under the leadership of University of Missouri Curators' Professor M. Frederick Hawthorne.
New International Osteoporosis Foundation report provides unique overview of osteoporosis in Europe, revealing the enormous disease burden and an unacceptable treatment gap; 71% of women at high risk of fracture are not receiving much-needed medication.
› Verified 3 days ago
| Entity Name | Torrance Health Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083903124 PECOS PAC ID: 1355302134 Enrollment ID: O20110819000276 |
News Archive
Hepatocellular carcinoma is an aggressive tumor with poor long-term prognosis. The reported 5-year recurrence rate ranges from 75% to 100%. Therefore, extrahepatic metastasis of HCC is uncommon due to the highly malignant nature of the primary tumor. However, with advances in different treatment modalities for HCC, the incidence of extrahepatic metastasis appears to be increasing.
"Have you ever been sexually active for a year or more without using contraception and becoming pregnant?" A study by George Mason University's Dean of the College of Health and Human Services, Dr. Germaine M. Buck Louis, and colleagues from the University at Albany and Eunice Kennedy Shriver National Institute of Child Health and Human Development suggests that asking this question could help clinicians better understand women and infants' health.
Researchers from the University of Texas have found an immunosuppressing target for the treatment of glioblastoma. In mice studies the team has identified CD73 macrophages which could be used to treat the cancers. The team also performed studies on human tumours to arrive at their conclusions. The study was published in the latest issue of the journal Nature Medicine this week.
Cancer painfully ends more than 500,000 lives in the United States each year, according to the Centers for Disease Control and Prevention. The scientific crusade against cancer recently achieved a victory under the leadership of University of Missouri Curators' Professor M. Frederick Hawthorne.
New International Osteoporosis Foundation report provides unique overview of osteoporosis in Europe, revealing the enormous disease burden and an unacceptable treatment gap; 71% of women at high risk of fracture are not receiving much-needed medication.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vanessa Lynn Dickey, MD 3285 Skypark Dr, Torrance, CA 90505-5004 Ph: (310) 750-3300 | Dr Vanessa Lynn Dickey, MD 3285 Skypark Dr, Torrance, CA 90505-5004 Ph: (310) 750-3300 |
News Archive
Hepatocellular carcinoma is an aggressive tumor with poor long-term prognosis. The reported 5-year recurrence rate ranges from 75% to 100%. Therefore, extrahepatic metastasis of HCC is uncommon due to the highly malignant nature of the primary tumor. However, with advances in different treatment modalities for HCC, the incidence of extrahepatic metastasis appears to be increasing.
"Have you ever been sexually active for a year or more without using contraception and becoming pregnant?" A study by George Mason University's Dean of the College of Health and Human Services, Dr. Germaine M. Buck Louis, and colleagues from the University at Albany and Eunice Kennedy Shriver National Institute of Child Health and Human Development suggests that asking this question could help clinicians better understand women and infants' health.
Researchers from the University of Texas have found an immunosuppressing target for the treatment of glioblastoma. In mice studies the team has identified CD73 macrophages which could be used to treat the cancers. The team also performed studies on human tumours to arrive at their conclusions. The study was published in the latest issue of the journal Nature Medicine this week.
Cancer painfully ends more than 500,000 lives in the United States each year, according to the Centers for Disease Control and Prevention. The scientific crusade against cancer recently achieved a victory under the leadership of University of Missouri Curators' Professor M. Frederick Hawthorne.
New International Osteoporosis Foundation report provides unique overview of osteoporosis in Europe, revealing the enormous disease burden and an unacceptable treatment gap; 71% of women at high risk of fracture are not receiving much-needed medication.
› Verified 3 days ago
Deborah Chon, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 100, Torrance, CA 90505 Phone: 310-542-6333 | |
Erika Joyce Kalash, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3565 Del Amo Blvd, Torrance, CA 90503 Phone: 310-214-0811 | |
Hosayn Khaleeli, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2245 Sepulveda Blvd, Torrance, CA 90501 Phone: 310-320-3204 Fax: 310-320-0919 | |
Mr. Anthony C Dike, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 20280 S Vermont Ave Ste 215, Torrance, CA 90502 Phone: 323-434-4626 Fax: 310-693-8082 | |
Paul J Brown, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3333 Skypark Dr, Torrance, CA 90505 Phone: 310-517-9006 | |
Dr. Philip W Chung, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2841 Lomita Blvd 215, Torrance, CA 90505 Phone: 310-379-2860 Fax: 310-325-1144 | |
Dr. Diane Jennifer Prager, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 300, Torrance, CA 90505 Phone: 310-325-8252 |